HDAC9 and Fabry disease: Regarding FD, evidence is available from transgenic mouse fibroblasts overexpressing a human α-Gal A mutation that HDAC inhibition rescues α-Gal A trafficking blockade, but without an effect on lysosomal Gb3 storage (Yam et al., 2007).